STAT+: A dispatch on AI from BIOtech’s big summer bash

At this year's BIO conference, the biotech industry showcased its growing interest in leveraging artificial intelligence to drive innovation and efficiency. Companies discussed how AI can enhance drug discovery, streamline clinical trials, and improve patient outcomes. The event highlighted the potential for AI to revolutionize the sector, but also raised questions about data privacy and the ethical use of AI technologies. As biotech firms increasingly adopt AI, this shift could redefine how new treatments are developed and delivered, marking a significant evolution in the industry.